Patient’s Qualitative Assessment of Treatment version 2 (PQATv2)

Sanofi Aventis

Distributed by Mapi Research Trust


Distributed by Mapi Research Trust

Basic description

  • Published in 2019
  • Created from the PQATv1

Sanofi Aventis

PQAT © Sanofi, 2016-2017
To provide early patient insights on benefits and disadvantages of drugs received within a clinical trial
Therapeutic area
  • Generic
Therapeutic indication


Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK, USA & Canada
Bibliographic reference(s) of the original questionnaire

Gater A, Reaney M, Findley A, Brun-Strang C, Burrows K, Nguyên-Pascal ML, Roborel de Climens A. Development and First Use of the Patient's Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit-Harm of Drugs Received During Clinical Studies. Drug Saf. 2020 Feb;43(2):119-134. (PubMed abstract)

Adam Gater, Matthew Reaney, Amy Findley, Catherine Brun-Strang, Kate Burrows, My-Liên Nguyên-Pascal and Aude Roborel de Climens. Tell me more: Exploring patient perspective on the benefits and disadvantages of drugs during clinical trials. #84209, DIA San Diego, USA, 2019 (Poster).

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use


Sanofi Aventis

Contact information

Mapi Research Trust
27 rue de la Villette
69003 Lyon
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.


Original language(s)

  • English for the UK, USA & Canada


The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.


Arabic for Israel*
Czech for Czech Republic*
Danish for Denmark*
English for Australia*
English for Canada*
English for Ireland*
English for New Zealand*
English for the UK*
English for the USA
French for Canada*
French for France*
German for Germany*
Greek for Greece*
Hebrew for Israel*
Hungarian for Hungary*
Italian for Italy*
Japanese for Japan*
Korean for South Korea*
Lithuanian for Lithuania*
Mandarin for China*
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil*
Russian for Israel*
Russian for Ukraine*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Turkish for Turkey*
Ukrainian for Ukraine*
* Performed by Mapi/ICON

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation:

Not authorized

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us